Anti-cyclic citrullinated peptide antibodies in type 1 autoimmune hepatitis (Q40375105)

19 September 2017

title

Anti-cyclic citrullinated peptide antibodies in type 1 autoimmune hepatitis (English)

1 reference

19 September 2017

Fusconi M

1 reference

19 September 2017

Vannini A

1 reference

19 September 2017

Dall'Aglio AC

1 reference

19 September 2017

Pappas G

1 reference

19 September 2017

Cassani F

1 reference

19 September 2017

Ballardini G

1 reference

19 September 2017

Frisoni M

1 reference

19 September 2017

Grassi A

1 reference

19 September 2017

Bianchi FB

1 reference

19 September 2017

Zauli D

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

Alimentary Pharmacology & Therapeutics

19 September 2017

published in

1 reference

19 September 2017

1 reference

19 September 2017

1 reference

19 September 2017

page(s)

951-955

1 reference

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02686.X

New challenges in hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02686.X

Antibodies to Ro/La, Cenp-B, and snRNPs antigens in autoimmune hepatitis of North America versus Asia: patterns of immunofluorescence, ELISA reactivities, and HLA association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02686.X

The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02686.X

Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02686.X

Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02686.X

Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02686.X

Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02686.X

PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02686.X

The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02686.X

Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02686.X

10.1111/J.1365-2036.2005.02686.X

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference